{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:53:18Z","timestamp":1790837598661,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ymthe.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T09:05:38Z","timestamp":1527498338000},"page":"1940-1952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia"],"prefix":"10.1016","volume":"26","author":[{"given":"Fran\u00e7oise","family":"Piguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charline","family":"de Montigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Vaucamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Reutenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Eisenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich\u2019s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2018.05.006_bib2","first-page":"3","article-title":"Friedreich ataxia: the clinical picture","volume":"256","author":"Pandolfo","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.ymthe.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich ataxia: neuropathology revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40478-016-0288-5","article-title":"Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation","volume":"4","author":"Koeppen","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-016-0326-3","article-title":"Purkinje cell injury, structural plasticity and fusion in patients with Friedreich\u2019s ataxia","volume":"4","author":"Kemp","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymthe.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2017.08.006","article-title":"Cerebral abnormalities in Friedreich ataxia: A review","volume":"84","author":"Selvadurai","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymthe.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ymthe.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich\u2019s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1868-7083-4-2","article-title":"Is Friedreich ataxia an epigenetic disorder?","volume":"4","author":"Kumari","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ymthe.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"e16199","DOI":"10.1371\/journal.pone.0016199","article-title":"Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU\/NFS1\/ISD11 iron-sulfur assembly complex","volume":"6","author":"Schmucker","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/ja308736e","article-title":"Mammalian frataxin controls sulfur production and iron entry during de novo Fe4S4 cluster assembly","volume":"135","author":"Colin","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ymthe.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2018.05.006_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0014-5793(02)02251-2","article-title":"Frataxin knockin mouse","volume":"512","author":"Miranda","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymthe.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s100480100118","article-title":"Rescue of the Friedreich\u2019s ataxia knockout mouse by human YAC transgenesis","volume":"3","author":"Pook","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ymthe.2018.05.006_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygeno.2004.04.003","article-title":"GAA repeat instability in Friedreich ataxia YAC transgenic mice","volume":"84","author":"Al-Mahdawi","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2018.05.006_bib17","first-page":"225","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich\u2019s ataxia","volume":"8","author":"Anjomani Virmouni","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jnc.12219","article-title":"Animal and cellular models of Friedreich ataxia","volume":"126","author":"Perdomini","year":"2013","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ymthe.2018.05.006_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4549-03.2004","article-title":"Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia","volume":"24","author":"Simon","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2018.05.006_bib21","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1371\/journal.pbio.0030159","article-title":"A developmental switch in the response of DRG neurons to ETS transcription factor signaling","volume":"3","author":"Hippenmeyer","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymthe.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrn2057","article-title":"Specification and connectivity of neuronal subtypes in the sensory lineage","volume":"8","author":"Marmig\u00e8re","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ymthe.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.33549\/physiolres.931738","article-title":"Parvalbumin and TRPV1 receptor expression in dorsal root ganglion neurons after acute peripheral inflammation","volume":"58","author":"Zacharov\u00e1","year":"2009","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ymthe.2018.05.006_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ng1097-215","article-title":"Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia","volume":"17","author":"R\u00f6tig","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00223234","article-title":"Cell number and cell density in the cerebellar cortex of man and some other mammals","volume":"157","author":"Lange","year":"1975","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymthe.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2015.01.010","article-title":"Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency","volume":"21","author":"Martelli","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2018.05.006_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","article-title":"GFAP and astrogliosis","volume":"4","author":"Eng","year":"1994","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2018.05.006_bib28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","article-title":"Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration","volume":"14","author":"Bostick","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2018.05.006_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-009-0589-x","article-title":"The dorsal root ganglion in Friedreich\u2019s ataxia","volume":"118","author":"Koeppen","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.20732","article-title":"Loss of Frataxin activates the iron\/sphingolipid\/PDK1\/Mef2 pathway in mammals","volume":"5","author":"Chen","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2018.05.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.30054","article-title":"Inducible and reversible phenotypes in a novel mouse model of Friedreich\u2019s Ataxia","volume":"6","author":"Chandran","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.ymthe.2018.05.006_bib32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2018.05.006_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2018.05.006_bib34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2012.015","article-title":"Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice","volume":"23","author":"Piguet","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2018.05.006_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1242\/dmm.017814","article-title":"Deletion of the App-Runx1 region in mice models human partial monosomy 21","volume":"8","author":"Arbogast","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ymthe.2018.05.006_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.20228","article-title":"Gait analysis detects early changes in transgenic SOD1(G93A) mice","volume":"32","author":"Wooley","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2018.05.006_bib37","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1002\/j.1460-2075.1986.tb04620.x","article-title":"Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos","volume":"5","author":"Sanes","year":"1986","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2018.05.006_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/ddi425","article-title":"Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy","volume":"15","author":"Sevin","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2018.05.006_bib39","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.15252\/emmm.201606349","article-title":"Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination","volume":"8","author":"Bolino","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2018.05.006_bib40","first-page":"860","article-title":"Clinical data and characterization of the liver conditional mouse model exclude neoplasia as a non-neurological manifestation associated with Friedreich\u2019s ataxia","volume":"5","author":"Martelli","year":"2012","journal-title":"Dis. Model. Mech."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618302090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001618302090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:52:48Z","timestamp":1761501168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001618302090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1525001618302090"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.05.006","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2018.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}